Loading...
Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
We report a case of refractory idiopathic childhood pyoderma gangrenosum in a young boy who had suffered from this disease since 3 years of age. He had unfavorable responses and intermittent relapses under different combinations of cytotoxic and steroid therapies. Although there was not much informa...
Na minha lista:
Udgivet i: | Biologics |
---|---|
Main Authors: | , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Dove
2019
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6554516/ https://ncbi.nlm.nih.gov/pubmed/31239637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S203753 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|